Sociedad Americana de Hirudoterapia

Aeromonas hydrophila infection associated with the use of medicinal leeches

Case report published in Journal of Clinical Microbiology (1989)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Case reportSeguridad y control de infeccionesSnower DP, Ruef C, Kuritza AP, Edberg SC · Journal of clinical microbiology, 1989

Abstract

The use of medicinal leeches (Hiruda medicinalis) is becoming more common after plastic surgery to control venous congestion of skin grafts. We describe a patient with Aeromonas hydrophila infection whose graft was treated with medicinal leeches. The infection required systemic antibiotic therapy. A. hydrophila is the predominant bacterial flora in the gut of the leech, where it plays an essential role for the animal in the digestion of blood. The potential for A. hydrophila wound infection, and appropriate antibiotic prophylaxis of the leech or patient, should be considered when medicinal leeches are used.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeCase ReportsJournal Article
Indexed MeSH termsAeromonasAnimalsBacterial InfectionsDisease VectorsFemaleHumansLeechesMiddle AgedSkin TransplantationWound Infection

Resumen

Seminal early case report of Aeromonas hydrophila infection in a skin graft patient treated with medicinal leeches, establishing the historical baseline for leech-borne infection literature.

Por qué esto importa para la hirudoterapia

This case report describes a patient who developed Aeromonas hydrophila wound infection after medicinal leech (Hirudo medicinalis) therapy was used to treat venous congestion following skin graft surgery. The infection required systemic antibiotic therapy, and the authors note that A. hydrophila is the predominant gut flora of the leech, essential for blood digestion but a potential pathogen in wounds. This is directly relevant to ASH's domain, as infection risk is a critical safety consideration in hirudotherapy. The caveat is that this is a single case report, so it illustrates risk rather than establishing incidence rates; however, the microbiological rationale for prophylactic antibiotics is clearly stated and clinically actionable.

Citación

Aeromonas hydrophila infection associated with the use of medicinal leeches.

Snower DP, Ruef C, Kuritza AP, Edberg SC · Journal of clinical microbiology, 1989

Contexto clínico relacionado

Explore cómo esta investigación se conecta con la práctica clínica

Añadido a la biblioteca ASH: May 26, 2026 · Última actualización del sitio: June 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.